Bayer plucks another oncology exec away from GlaxoSmithKline as it continues prostate cancer push
A couple months after Bayer lured away a top GlaxoSmithKline oncology exec, the German pharma has struck again.
Bayer is naming Tara Frenkl as head of oncology development at its oncology strategic business unit, the company announced Thursday, and said her first day will be Monday. Frenkl will report to Christine Roth, the previous GSK vet Bayer plucked away back in February, once she gets going.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.